M. Gleave

发表

The suppression of human prostate tumor growth in mice by the intratumoral injection of a slow-release polymeric paste formulation of paclitaxel.

W. Hunter, E. Beraldi, H. Burt, 2000, Cancer research.

Synergistic chemosensitization and inhibition of progression to androgen independence by antisense Bcl‐2 oligodeoxynucleotide and paclitaxel in the LNCaP prostate tumor model

M. Gleave, A. Tolcher, H. Miyake, 2001, International journal of cancer.

Castration-induced apoptosis of androgen-dependent shionogi carcinoma is associated with increased expression of genes encoding insulin-like growth factor-binding proteins.

M. Gleave, H. Miyake, M. Pollak, 1999, Cancer research.

Enhanced sensitivity to androgen withdrawal due to overexpression of interleukin-6 in androgen-dependent human prostate cancer LNCaP cells

H. Miyake, M. Fujisawa, M. Gleave, 2009, British Journal of Cancer.

Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer.

H. Miyake, P. Rennie, C. Nelson, 2000, Cancer research.

Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo.

H. Miyake, K. Chi, M. Gleave, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models.

M. Gleave, H. Miyake, M. Pollak, 2000, Cancer research.

Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models.

H. Miyake, P. Rennie, C. Nelson, 2000, Cancer research.

Polymeric micellar paclitaxel phosphorylates Bcl‐2 and induces apoptotic regression of androgen‐independent LNCaP prostate tumors

M. Gleave, H. Miyake, H. Burt, 2000, The Prostate.

Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway.

M. Gleave, H. Miyake, P. Rennie, 2000, Endocrinology.

Acquisition of resistance to Fas-mediated apoptosis by overexpression of clusterin in human renal-cell carcinoma cells.

H. Miyake, S. Kamidono, T. Zellweger, 2001, Molecular urology.

Inhibition of progression to androgen‐independence by combined adjuvant treatment with antisense BCL‐XL and antisense Bcl‐2 oligonucleotides plus taxol after castration in the Shionogi tumor model

M. Gleave, H. Miyake, B. Monia, 2000, International journal of cancer.

A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice.

M. Gleave, N. Sato, N. Bruchovsky, 1997, Cancer research.

Synergistic chemsensitization and inhibition of tumor growth and metastasis by the antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model.

H. Miyake, S. Kamidono, M. Gleave, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

THE COX-2 INHIBITOR ETORICOXIB DID NOT ALTER THE ANTI-PLATELET EFFECTS OF LOW-DOSE ASPIRIN IN HEALTHY VOLUNTEERS.

S. Waldman, W. Kraft, H. Greenberg, 2001 .

Relationship of Arachidonic Acid Concentration to Cyclooxygenase‐Dependent Human Platelet Aggregation

S. Waldman, G. Pitari, W. Kraft, 2003, Journal of clinical pharmacology.